ThomasJosephKaleyMD

Neurooncology

Instructor, Neurology & Neuroscience, Weill Cornell Medical College

Overview of Dr. Kaley

Dr. Thomas Kaley is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, New York-Presbyterian Hospital, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from New York University Grossman School of Medicine and has been in practice 14 years. Dr. Kaley accepts several types of health insurance, listed below. He is one of 63 doctors at Memorial Sloan Kettering Cancer Center and one of 66 doctors at NYC Health + Hospitals / Bellevue who specialize in Neurology. He has more than 60 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(917) 983-1752

Education & Training

NYU Grossman School of MedicineResidency, Neurology, 2004 - 2007
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2003 - 2004
New York University School of MedicineClass of 2003

Certifications & Licensure

NJ State Medical License 2018 - 2025
NY State Medical License 2004 - 2025
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma Start of enrollment: 2007 Jun 01
Completed
Phase 2
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Start of enrollment: 2007 Oct 01
Completed
Phase 2
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas Start of enrollment: 2006 May 01
Completed
Phase 2
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Start of enrollment: 2009 Nov 17
Active, not recruiting
Phase 3
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2010 Jan 27
Completed
Phase 1, Phase 2
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2013 Aug 19
Active, not recruiting
Phase 1
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma Start of enrollment: 2013 Jun 01
Active, not recruiting
Not Applicable
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas Start of enrollment: 2014 Dec 08
Completed
Phase 1
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors Start of enrollment: 2017 Jul 13
Active, not recruiting
Phase 2
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma Start of enrollment: 2023 Jun 19
Withdrawn
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab.
Sarah E Lochrin, Darren J Buonocore, Robert J Young, Thomas J Kaley, Michael A Postow
Pigment Cell & Melanoma Research. 2024-11-01
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.
Richard A Hickman, Alexandra M Miller, Bridget M Holle, Justin Jee, Si-Yang Liu
Acta Neuropathologica Communications. 2024-09-17
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Christian Grommes, Subhiksha Nandakumar, Lauren R Schaff, Igor Gavrilovic, Thomas J Kaley
Clinical Cancer Research. 2024-09-13

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Health Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment